Skip to main content
SpringerLink
Log in

Fibromyalgia Developed after Administration of Gonadotrophin- Releasing Hormone Analogue

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract:

We report the case of a woman treated with a gonadotrophin-releasing hormone analogue for endometriosis who developed typical clinical features of fibromyalgia, with widespread musculoskeletal pain, sleep difficulties, neuropsychological complaints and tender points on clininal examination. The gonadotrophin-releasing hormone analogue treatment probably induced disturbances in the neuroendocrine system and the secretion of neurotransmitters, and may be suspected to be the cause of this case of fibromyalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. University Hospital Jean Minjoz, Besançon, France, France

    E. Toussirot & D. Wendling

Authors
  1. E. Toussirot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Wendling
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 3 May 2000 / Accepted: 25 October 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toussirot, E., Wendling, D. Fibromyalgia Developed after Administration of Gonadotrophin- Releasing Hormone Analogue. Clin Rheumatol 20, 150–152 (2001). https://doi.org/10.1007/PL00011195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00011195

Search

Navigation